This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 1999 Jun;45(6):689-92.

doi: 10.1002/1531-8249(199906)45:6<689::aid-ana1>3.0.co;2-m.

Interleukin-12: amiss in MS

C L Karp

PMID: 10360759
DOI: 10.1002/1531-8249(199906)45:6<689::aid-ana1>3.0.co;2-m

Editorial

Interleukin-12: amiss in MS

C L Karp. Ann Neurol. 1999 Jun.

. 1999 Jun;45(6):689-92.

doi: 10.1002/1531-8249(199906)45:6<689::aid-ana1>3.0.co;2-m.

Author

C L Karp

PMID: 10360759
DOI: 10.1002/1531-8249(199906)45:6<689::aid-ana1>3.0.co;2-m

No abstract available

PubMed Disclaimer

Comment on

Decreased interleukin-10 and increased interleukin-12p40 mRNA are associated with disease activity and characterize different disease stages in multiple sclerosis.
van Boxel-Dezaire AH, Hoff SC, van Oosten BW, Verweij CL, Dräger AM, Adèr HJ, van Houwelingen JC, Barkhof F, Polman CH, Nagelkerken L. van Boxel-Dezaire AH, et al. Ann Neurol. 1999 Jun;45(6):695-703. doi: 10.1002/1531-8249(199906)45:6<695::aid-ana3>3.0.co;2-r. Ann Neurol. 1999. PMID: 10360761

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Wiley
Medical
- MedlinePlus Health Information